5 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Santen Pharmaceutical and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$74Mraised across 5 rounds since 2000, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Bpifrance
Idinvest Partners
Auriga Partners
Omnes
123Venture
Innovation CapitalFrom a historical funding record
From a historical funding record
From a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Auriga PartnersInnovation CapitalBpifranceOmnesEdmond de Rothschild Venture Capital123VentureIdinvest PartnersGroupe SiparexMissing a round, or an investor who was in one? Tell us.
Santen Pharmaceutical's investors include Auriga Partners, Innovation Capital, Bpifrance, Omnes and Edmond de Rothschild Venture Capital, and 3 more on record.
Santen Pharmaceutical has raised $74M across 5 rounds since 2000.
Santen Pharmaceutical's most recent round was a Series D of $22M in Sept 2009.
Santen Pharmaceutical's largest round on record is $32M (Series C), in Apr 2006.
Santen Pharmaceutical's first round on record, in Jan 2000, was backed by Auriga Partners and Innovation Capital.
Santen Pharmaceutical's latest named round is a Series D, in Sept 2009.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.